Cargando…
Mapping the immunosuppressive environment in uterine tumors: implications for immunotherapy
The major hurdle for cancer vaccines to be effective is posed by tumor immune evasion. Several common immune mechanisms and mediators are exploited by tumors to avoid immune destruction. In an attempt to shed more light on the immunosuppressive environment in uterine tumors, we analyzed the presence...
Autores principales: | Vanderstraeten, Anke, Luyten, Catherine, Verbist, Godelieve, Tuyaerts, Sandra, Amant, Frederic |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4024136/ https://www.ncbi.nlm.nih.gov/pubmed/24658839 http://dx.doi.org/10.1007/s00262-014-1537-8 |
Ejemplares similares
-
In Vitro Assessment of the Expression and T Cell Immunogenicity of the Tumor-Associated Antigens BORIS, MUC1, hTERT, MAGE-A3 and Sp17 in Uterine Cancer
por: Vanderstraeten, Anke, et al.
Publicado: (2016) -
Potential Therapeutic Targets in Uterine Sarcomas
por: Cuppens, Tine, et al.
Publicado: (2015) -
Endometrial Stromal Sarcomas: A Revision of Their Potential as Targets for Immunotherapy
por: Tuyaerts, Sandra, et al.
Publicado: (2018) -
Variability in CRP, regulatory T cells and effector T cells over time in gynaecological cancer patients: a study of potential oscillatory behaviour and correlations
por: Madondo, Mutsa T, et al.
Publicado: (2014) -
Resistance to Immune Checkpoint Blockade in Uterine Leiomyosarcoma: What Can We Learn from Other Cancer Types?
por: De Wispelaere, Wout, et al.
Publicado: (2021)